Prior Movesmirror the world’s best investors
Preview. Tables on this page show their first five rows. Sign in if you subscribe, or see what Pro includes.

OSCR: who owns it, and who’s predicted to buy next

Oscar Health Inc - Class A · Health Care · on the Prior Moves forward board for 2026-09-30 at rank #43. Research, not investment advice.

78 PriorScorelast close $34.013m momentum 9.5%

Predicted to buy next quarter

3 tracked investors are included in the model-ranked expectations for OSCR in 2026-09-30. This is a forecast about a later filing, not a confirmation that anyone has bought the security or a recommendation to do so.

Strongest ranked investor signal: Daniel Loeb. No calibrated purchase probability is shown.

Currently disclosed holders

No investor in our tracked set discloses OSCR in their latest 13F. The prediction above is a forward call, not a mirror of current holdings.

Mutual fund and ETF holders

156 US mutual funds and ETFs from 90 fund families reported a position in OSCR for the quarter ending 2026-06-30. Against their own report a quarter earlier, 71 raised shares, 45 opened a new position, 22 cut and 2 sold out. Source: SEC Form N-PORT, which funds file about 60 days after quarter end. Share counts, not trades: a change can reflect fund inflows rather than a decision about OSCR.

Fund familyFundsShare of fund-held shares
Vanguard Index Funds441.5%
Ishares Trust519.6%
T. Rowe Price Small-Cap Stock Fund, Inc.16.7%
T. Rowe Price Small-Cap Value Fund, Inc.14.6%
Fidelity Covington Trust64.0%
T. Rowe Price Equity Funds, Inc.13.6%
T. Rowe Price Integrated Equity Funds, Inc.12.4%
T. Rowe Price New Horizons Fund, Inc.11.9%
The weekly digest

The predicted next buys, fresh disclosures, and the week’s catalysts. One email a week. Honest numbers, never advice.

See the full ranked board on top picks, how the PriorScore is built on how it works, the honest edge numbers on methodology, and the running accuracy on the prediction leaderboard. Forward quarter 2026-09-30, data as of 2026-10-16. Research, not investment advice, see the disclaimer.